TNFSF10 and breast carcinoma: Ruiz-Ruiz and Lopez-Rivas [33] have suggested that, in breast cancer cell lines, IFNγ favors activation of mitochondria-operated apoptotic pathway by TRAIL; this activation can be inhibited in bcl-2 overexpressing cells.